Burden of liver diseases in the world

被引:2335
作者
Asrani, Sumeet K. [1 ]
Devarbhavi, Harshad [2 ]
Eaton, John [3 ]
Kamath, Patrick S. [3 ]
机构
[1] Baylor Univ, Med Ctr, Dallas, TX USA
[2] St Johns Med Coll Hosp, Bangalore, Karnataka, India
[3] Mayo Clin, Coll Med, Rochester, MN USA
关键词
Chronic liver disease; Burden; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; HEPATITIS-E VIRUS; CLINICAL-PRACTICE GUIDELINES; SINGLE-CENTER EXPERIENCE; HEALTH-CARE BURDEN; BODY-MASS INDEX; HEPATOCELLULAR-CARCINOMA; GLOBAL BURDEN;
D O I
10.1016/j.jhep.2018.09.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular carcinoma. Cirrhosis is currently the 11th most common cause of death globally and liver cancer is the 16th leading cause of death; combined, they account for 3.5% of all deaths worldwide. Cirrhosis is within the top 20 causes of disability-adjusted life years and years of life lost, accounting for 1.6% and 2.1% of the worldwide burden. About 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. Approximately 2 billion adults are obese or overweight and over 400 million have diabetes; both of which are risk factors for nonalcoholic fatty liver disease and hepatocellular carcinoma. The global prevalence of viral hepatitis remains high, while drug-induced liver injury continues to increase as a major cause of acute hepatitis. Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates. Though these numbers are sobering, they highlight an important opportunity to improve public health given that most causes of liver diseases are preventable. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 171
页数:21
相关论文
共 232 条
  • [51] A genetic study of Wilson's disease in the United Kingdom
    Coffey, Alison J.
    Durkie, Miranda
    Hague, Stephen
    McLay, Kirsten
    Emmerson, Jennifer
    Lo, Christine
    Klaffke, Stefanie
    Joyce, Christopher J.
    Dhawan, Anil
    Hadzic, Nedim
    Mieli-Vergani, Giorgina
    Kirk, Richard
    Allen, K. Elizabeth
    Nicholl, David
    Wong, Siew
    Griffiths, William
    Smithson, Sarah
    Giffin, Nicola
    Taha, Ali
    Connolly, Sally
    Gillett, Godfrey T.
    Tanner, Stuart
    Bonham, Jim
    Sharrack, Basil
    Palotie, Aarno
    Rattray, Magnus
    Dalton, Ann
    Bandmann, Oliver
    [J]. BRAIN, 2013, 136 : 1476 - 1487
  • [52] Cooksley W G, 2000, J Viral Hepat, V7 Suppl 1, P1, DOI 10.1046/j.1365-2893.2000.00021.x
  • [53] Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
    D'Amico, G
    Garcia-Tsao, G
    Pagliaro, L
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 217 - 231
  • [54] Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients
    D'Amico, G.
    Pasta, L.
    Morabito, A.
    D'Amico, M.
    Caltagirone, M.
    Malizia, G.
    Tine, F.
    Giannuoli, G.
    Traina, M.
    Vizzini, G.
    Politi, F.
    Luca, A.
    Virdone, R.
    Licata, A.
    Pagliaro, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1180 - 1193
  • [55] Clinical states of cirrhosis and competing risks
    D'Amico, Gennaro
    Morabito, Alberto
    D'Amico, Mario
    Pasta, Linda
    Malizia, Giuseppe
    Rebora, Paola
    Valsecchi, Maria Grazia
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 (03) : 563 - 576
  • [56] Large-Scale Characterization Study of Patients With Antimitochondrial Antibodies but Nonestablished Primary Biliary Cholangitis
    Dahlqvist, Geraldine
    Gaouar, Farid
    Carrat, Fabrice
    Meurisse, Sofia
    Chazouilleres, Olivier
    Poupon, Raoul
    Johanet, Catherine
    Corpechot, Christophe
    [J]. HEPATOLOGY, 2017, 65 (01) : 152 - 163
  • [57] Acute and clinically relevant drug-induced liver injury:: a population based case-control study
    de Abajo, FJ
    Montero, D
    Madurga, M
    Rodríguez, LAG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 71 - 80
  • [58] Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
    de Boer, Ynto S.
    van Gerven, Nicole M. F.
    Zwiers, Antonie
    Verwer, Bart J.
    van Hoek, Bart
    van Erpecum, Karel J.
    Beuers, Ulrich
    van Buuren, Henk R.
    Drenth, Joost P. H.
    den Ouden, Jannie W.
    Verdonk, Robert C.
    Koek, Ger H.
    Brouwer, Johannes T.
    Guichelaar, Maureen M. J.
    Vrolijk, Jan M.
    Kraal, Georg
    Mulder, Chris J. J.
    van Nieuwkerk, Carin M. J.
    Fischer, Janett
    Berg, Thomas
    Stickel, Felix
    Sarrazin, Christoph
    Schramm, Christoph
    Lohse, Ansgar W.
    Weiler-Normann, Christina
    Lerch, Markus M.
    Nauck, Matthias
    Voelzke, Henry
    Homuth, Georg
    Bloemena, Elisabeth
    Verspaget, Hein W.
    Kumar, Vinod
    Zhernakova, Alexandra
    Wijmenga, Cisca
    Franke, Lude
    Bouma, Gerd
    [J]. GASTROENTEROLOGY, 2014, 147 (02) : 443 - +
  • [59] Liver transplantation in Spain
    de la Rosa, Gloria
    Fondevila, Constantino
    Navasa, Miquel
    [J]. LIVER TRANSPLANTATION, 2016, 22 (09) : 1259 - 1264
  • [60] World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
    de Martel, Catherine
    Maucort-Boulch, Delphine
    Plummer, Martyn
    Franceschi, Silvia
    [J]. HEPATOLOGY, 2015, 62 (04) : 1190 - 1200